KRAS c.287A>C ;(p.Y96S)

Variant ID: 12-25380171-T-G

NM_004985.3(KRAS):c.287A>C;(p.Y96S)

This variant was identified in 12 publications

View GRCh38 version.




Publications:


Recent Advances in Covalent Drug Discovery.

Pharmaceuticals (Basel, Switzerland)
Schaefer, Daniel D; Cheng, Xinlai X
Publication Date: 2023-04-28

Variant appearance in text: KRAS: Y96S
PubMed Link: 37242447
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-16-00663.pdf
View BVdb publication page



Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Translational Lung Cancer Research
Santarpia, Mariacarmela M; Ciappina, Giuliana G; Spagnolo, Calogera Claudia CC; Squeri, Andrea A; Passalacqua, Maria Ilenia MI; Aguilar, Andrés A; Gonzalez-Cao, Maria M; Giovannetti, Elisa E; Silvestris, Nicola N; Rosell, Rafael R
Publication Date: 2023-02-28

Variant appearance in text: KRAS: Y96S
PubMed Link: 36895930
Variant Present in the following documents:
  • Main text
  • tlcr-12-02-346.pdf
View BVdb publication page



Targeting KRAS G12C mutations in colorectal cancer.

Gastroenterology Report
Zhao, Ming-He MH; Wu, Ai-Wen AW
Publication Date: 2023

Variant appearance in text: KRAS: Y96S
PubMed Link: 36632627
Variant Present in the following documents:
  • Main text
  • goac083.pdf
View BVdb publication page



A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib.

Lung Cancer (Auckland, N.Z.)
Brazel, Danielle D; Arter, Zhaohui Z; Nagasaka, Misako M
Publication Date: 2022

Variant appearance in text: KRAS: Y96S
PubMed Link: 36387582
Variant Present in the following documents:
  • Main text
  • lctt-13-75.pdf
View BVdb publication page



Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance.

Cancers
Ashrafi, Adnin A; Akter, Zakia Z; Modareszadeh, Pouya P; Modareszadeh, Parsa P; Berisha, Eranda E; Alemi, Parinaz Sadat PS; Chacon Castro, Maria Del Carmen MDC; Deese, Alexander R AR; Zhang, Li L
Publication Date: 2022-09-20

Variant appearance in text: KRAS: Y96S
PubMed Link: 36230484
Variant Present in the following documents:
  • Main text
  • cancers-14-04562.pdf
View BVdb publication page



Emerging insights to lung cancer drug resistance.

Cancer Drug Resistance (Alhambra, Calif.)
Su, Chunxia C
Publication Date: 2022

Variant appearance in text: KRAS: Y96S
PubMed Link: 36176761
Variant Present in the following documents:
  • cdr-5-3-534.pdf
View BVdb publication page



The current state of the art and future trends in RAS-targeted cancer therapies.

Nature Reviews. Clinical Oncology
Punekar, Salman R SR; Velcheti, Vamsidhar V; Neel, Benjamin G BG; Wong, Kwok-Kin KK
Publication Date: 2022-10

Variant appearance in text: KRAS: Y96S
PubMed Link: 36028717
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies.

Frontiers In Oncology
Désage, Anne-Laure AL; Léonce, Camille C; Swalduz, Aurélie A; Ortiz-Cuaran, Sandra S
Publication Date: 2022

Variant appearance in text: KRAS: Y96S
PubMed Link: 35251972
Variant Present in the following documents:
  • Main text
  • fonc-12-796832.pdf
View BVdb publication page



Targeting KRAS in Non-Small Cell Lung Cancer.

Frontiers In Oncology
Corral de la Fuente, Elena E; Olmedo Garcia, Maria Eugenia ME; Gomez Rueda, Ana A; Lage, Yolanda Y; Garrido, Pilar P
Publication Date: 2021

Variant appearance in text: KRAS: Y96S
PubMed Link: 35083149
Variant Present in the following documents:
  • Main text
  • fonc-11-792635.pdf
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: KRAS: Y96S
PubMed Link: 34885068
Variant Present in the following documents:
  • Main text
  • cancers-13-05956.pdf
View BVdb publication page



Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.

Cancers
Sunaga, Noriaki N; Miura, Yosuke Y; Kasahara, Norimitsu N; Sakurai, Reiko R
Publication Date: 2021-11-26

Variant appearance in text: KRAS: Y96S
PubMed Link: 34885068
Variant Present in the following documents:
  • Main text
  • cancers-13-05956.pdf
View BVdb publication page



Spotlight on Sotorasib (AMG 510) for KRAS G12C Positive Non-Small Cell Lung Cancer.

Lung Cancer (Auckland, N.Z.)
Zhang, Shannon S SS; Nagasaka, Misako M
Publication Date: 2021

Variant appearance in text: KRAS: Y96S
PubMed Link: 34675734
Variant Present in the following documents:
  • Main text
View BVdb publication page



Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges.

Molecular Cancer
Tang, Daolin D; Kroemer, Guido G; Kang, Rui R
Publication Date: 2021-10-04

Variant appearance in text: KRAS: Y96S
PubMed Link: 34607583
Variant Present in the following documents:
  • Main text
  • 12943_2021_Article_1422.pdf
View BVdb publication page